Online analysis based on ERS 2022 mentions
in the period 28 August – 10 September 2022

4 Sept – 6 Sept 2022

This year’s European Respiratory Society’s Congress (ERS) was held in Barcelona, Spain. The event welcomed thousands of delegates to unravel the newest advances in respiratory medicine and science. The scientific programme featured cutting-edge scientific sessions, practical workshops, interactive educational content and networking opportunities for visitors and companies that both exhibited and attended the congress.

Activity Over Time:

Brand Buzz:

SLEEP-RELATED DISORDERS

TREATMENT OF SLEEP DISORDERS

COVID-19

TRAINING & EDUCATION

INNOVATIONS

Sleep | Respiratory Care & Therapy | New Product Release

In comparison to last year’s ERS Brand Buzz Report, the top 5 most discussed topics have changed slightly. With COVID-19 now taking the third place, followed by Training & Education and Innovations in Sleep Care & Therapy, the first and second places are taken by two brand new topics—Sleep-Related Disorders and Treatment of Sleep Disorders (including medication).

In Twitter only, COVID-19 ranked higher than Training Education & Innovations.

Relative shares are calculated out of all categorised posts within the respective social media.

Competitive Brand Buzz:

Influencers & Online Buzz Strategies:

What did the highest-ranking companies in Brand Buzz analysis talk about? Click on the three dots below to flip between tabs.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

Chiesi’s focus during this year’s ERS Congress narrowed to three different areas of study, but what stood out was the company’s dedication to co-creating smart and human solutions. The company supported the launch of the new International Respiratory Coalition ‘Lung Facts’—a web-based tool with key economical and epidemiological data for respiratory conditions across Europe.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

GSK’s top voices—Dr. Susie Barnes, Dr. Marco Avila and Dr. Piyali Mukherjee presented 31 abstracts from the brand’s portfolio of biologics, vaccines and inhaled medicines. Their research aims to redefine what is possible for patients.

INFLUENCER & INDUSTRY

CAMPAIGN & PITCH

AstraZeneca took a closer look at chronic respiratory and immune-mediated diseases. The company strives to transform care, with bold ambition to go beyond controlling symptoms, to slow down or reverse the course of disease.

TOP 10 Influencers by Conversation Impact:

INFLUENCER:

FOLLOWERS:

Marko Topalovic

Helps interpretation of pulmonary function tests | Co-Founder & CEO at ArtiQ

500+

Paul Rowe, MD, ATSF

Vice President, Head of Global Medical, Immunology at Sanofi

9567

n/a

Jason Weatherald

Assistant Professor at University of Calgary

105

2279

James D Chalmers

Asthma and Lung UK Chair of Respiratory Research, University of Dundee. Deputy Editor of ERJ.

5874

Ayodeji Adegunsoye MD FACP FCCP

Assistant Professor at University of Chicago

500+

1798

Alexandre Kawassaki

LinkedIn TopVoice Saúde 2020. Pneumologista do Grupo de Doenças Intersticiais – HCFMUSP, na Clínica de Doenças Respiratórias Avançadas, no Hospital 9 de Julho e no Hospital Israelita Albert Einstein